Voyager Therapeutics Q2 EPS $(0.57) Misses $(0.54) Estimate, Sales $5.20M Miss $9.91M Estimate
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.54) by 5.95 percent. This is a 216.67 percent decrease over losses of $(0.18) per share
